Serving To Educate Primary Care Clinicians On Respiratory Issues
Evidence Based Medicine Header 1
Medical Education Header 2
Peer-to-peer Exchange Header 3
Metabolic Diseases Header 4
News: Articles from our Partners at Consultant 360 July 2017

New Respiratory Disease Articles from our Partners at Consultant 360

HF Duration May Be Linked With Dyspnea, Mortality After Hospitalization

http://bit.ly/2sv1V1O

In a recent study, researchers analyzed rates of dyspnea relief and survival post-hospitalization in patients with newly-diagnosed or chronic HF.

 Are E-Cigarettes Less Addictive Than Regular Cigarettes?

http://bit.ly/2tuuh07

Penn State recently released some results from the ongoing PATH study regarding users’ dependency on e-cigarettes and regular cigarettes. To see the current results, as well as future plans for the PATH study, read more.

 Study: Certain Antibiotics Often Overprescribed, Despite Guidelines

http://bit.ly/2s9ZsO5

Inappropriate antibiotic use is a contributing factor to rising antibiotic resistance rates. A recent study examined trends in antibiotic prescriptions for acute respiratory tract infections to determine if national guidelines to promote antibiotic stewardship are being followed.

 Vascular Pruning Predicts Mortality Risk in Smokers

http://bit.ly/2rDm0nE

In a recent study presented at the American Thoracic Society 2017 International Conference, researchers tested the hypothesis that vascular pruning could be used to predict mortality in individuals who smoked, and whether the presence of chronic obstructive pulmonary disease affected the association.

 Study Details Drug-Drug Interactions within Combination Therapies for PAH

http://bit.ly/2rXiM1x

A recent study investigated pharmacokinetic interactions between phosphodiesterase type 5 inhibitors and endothelin receptor antagonists used in combination for the treatment of pulmonary arterial hypertension.